EXOSENS SAS (EXENS.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:EXENS - FR001400Q9V2 - Common Stock
47.3 EUR
-1 (-2.07%)
Taking everything into account, EXENS scores 5 out of 10 in our fundamental rating. EXENS was compared to 49 industry peers in the Aerospace & Defense industry. EXENS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. EXENS is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
EXENS had positive earnings in the past year.
EXENS had a positive operating cash flow in the past year.
1.2 Ratios
EXENS has a Return On Assets (3.54%) which is comparable to the rest of the industry.
The Return On Equity of EXENS (7.14%) is worse than 61.22% of its industry peers.
EXENS's Return On Invested Capital of 7.97% is in line compared to the rest of the industry. EXENS outperforms 55.10% of its industry peers.
EXENS had an Average Return On Invested Capital over the past 3 years of 7.01%. This is below the industry average of 9.30%.
The 3 year average ROIC (7.01%) for EXENS is below the current ROIC(7.97%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 7.14% | ||
| ROIC | 7.97% |
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)7.53%
ROE(5y)N/A
ROIC(3y)7.01%
ROIC(5y)N/A
1.3 Margins
EXENS has a better Profit Margin (7.79%) than 73.47% of its industry peers.
Looking at the Operating Margin, with a value of 18.28%, EXENS belongs to the top of the industry, outperforming 95.92% of the companies in the same industry.
EXENS has a better Gross Margin (73.86%) than 95.92% of its industry peers.
EXENS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.28% | ||
| PM (TTM) | 7.79% | ||
| GM | 73.86% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXENS is destroying value.
The number of shares outstanding for EXENS has been reduced compared to 1 year ago.
The debt/assets ratio for EXENS has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.47 indicates that EXENS is not in any danger for bankruptcy at the moment.
EXENS's Altman-Z score of 4.47 is amongst the best of the industry. EXENS outperforms 81.63% of its industry peers.
The Debt to FCF ratio of EXENS is 4.69, which is a neutral value as it means it would take EXENS, 4.69 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.69, EXENS is in the better half of the industry, outperforming 69.39% of the companies in the same industry.
EXENS has a Debt/Equity ratio of 0.61. This is a neutral value indicating EXENS is somewhat dependend on debt financing.
EXENS has a Debt to Equity ratio of 0.61. This is comparable to the rest of the industry: EXENS outperforms 40.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 4.69 | ||
| Altman-Z | 4.47 |
ROIC/WACC0.98
WACC8.17%
2.3 Liquidity
EXENS has a Current Ratio of 2.51. This indicates that EXENS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.51, EXENS belongs to the best of the industry, outperforming 89.80% of the companies in the same industry.
A Quick Ratio of 1.67 indicates that EXENS should not have too much problems paying its short term obligations.
EXENS's Quick ratio of 1.67 is amongst the best of the industry. EXENS outperforms 87.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 102.95% over the past year.
EXENS shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.04%.
EXENS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.36% yearly.
EPS 1Y (TTM)102.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%875.18%
Revenue 1Y (TTM)35.04%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%20.13%
3.2 Future
EXENS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.39% yearly.
Based on estimates for the next years, EXENS will show a quite strong growth in Revenue. The Revenue will grow by 13.35% on average per year.
EPS Next Y55.61%
EPS Next 2Y37.92%
EPS Next 3Y30.34%
EPS Next 5Y25.39%
Revenue Next Year18.67%
Revenue Next 2Y16.4%
Revenue Next 3Y14.65%
Revenue Next 5Y13.35%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 63.92, the valuation of EXENS can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of EXENS indicates a slightly more expensive valuation: EXENS is more expensive than 65.31% of the companies listed in the same industry.
EXENS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.76.
The Price/Forward Earnings ratio is 25.10, which means the current valuation is very expensive for EXENS.
EXENS's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.96. EXENS is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.92 | ||
| Fwd PE | 25.1 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXENS is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as EXENS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.2 | ||
| EV/EBITDA | 23.2 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
EXENS's earnings are expected to grow with 30.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.15
PEG (5Y)N/A
EPS Next 2Y37.92%
EPS Next 3Y30.34%
5. Dividend
5.1 Amount
EXENS has a yearly dividend return of 0.22%, which is pretty low.
EXENS's Dividend Yield is slightly below the industry average, which is at 1.18.
With a Dividend Yield of 0.22, EXENS pays less dividend than the S&P500 average, which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.22% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y37.92%
EPS Next 3Y30.34%
EPA:EXENS (12/11/2025, 7:00:00 PM)
47.3
-1 (-2.07%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners47.07%
Inst Owner ChangeN/A
Ins Owners1.86%
Ins Owner ChangeN/A
Market Cap2.41B
Revenue(TTM)394.08M
Net Income(TTM)30.68M
Analysts76.67
Price Target49.47 (4.59%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.22% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.46%
PT rev (3m)14.12%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.07%
EPS NY rev (3m)-1.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-0.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.92 | ||
| Fwd PE | 25.1 | ||
| P/S | 6.11 | ||
| P/FCF | 42.2 | ||
| P/OCF | 23.83 | ||
| P/B | 5.61 | ||
| P/tB | N/A | ||
| EV/EBITDA | 23.2 |
EPS(TTM)0.74
EY1.56%
EPS(NY)1.88
Fwd EY3.98%
FCF(TTM)1.12
FCFY2.37%
OCF(TTM)1.98
OCFY4.2%
SpS7.74
BVpS8.43
TBVpS-0.02
PEG (NY)1.15
PEG (5Y)N/A
Graham Number11.85
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 7.14% | ||
| ROCE | 9.7% | ||
| ROIC | 7.97% | ||
| ROICexc | 9.07% | ||
| ROICexgc | 26.62% | ||
| OM | 18.28% | ||
| PM (TTM) | 7.79% | ||
| GM | 73.86% | ||
| FCFM | 14.49% |
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)7.53%
ROE(5y)N/A
ROIC(3y)7.01%
ROIC(5y)N/A
ROICexc(3y)7.64%
ROICexc(5y)N/A
ROICexgc(3y)25.3%
ROICexgc(5y)N/A
ROCE(3y)8.53%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 4.69 | ||
| Debt/EBITDA | 2.32 | ||
| Cap/Depr | 105.56% | ||
| Cap/Sales | 11.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 88.9% | ||
| Profit Quality | 186.1% | ||
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.47 |
F-Score6
WACC8.17%
ROIC/WACC0.98
Cap/Depr(3y)105.99%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.64%
Cap/Sales(5y)N/A
Profit Quality(3y)171.48%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%875.18%
EPS Next Y55.61%
EPS Next 2Y37.92%
EPS Next 3Y30.34%
EPS Next 5Y25.39%
Revenue 1Y (TTM)35.04%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%20.13%
Revenue Next Year18.67%
Revenue Next 2Y16.4%
Revenue Next 3Y14.65%
Revenue Next 5Y13.35%
EBIT growth 1Y45.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.83%
EBIT Next 3Y32.62%
EBIT Next 5Y25.17%
FCF growth 1Y181.68%
FCF growth 3Y33.59%
FCF growth 5YN/A
OCF growth 1Y90.75%
OCF growth 3Y31.16%
OCF growth 5YN/A
EXOSENS SAS / EXENS.PA FAQ
What is the fundamental rating for EXENS stock?
ChartMill assigns a fundamental rating of 5 / 10 to EXENS.PA.
What is the valuation status of EXOSENS SAS (EXENS.PA) stock?
ChartMill assigns a valuation rating of 3 / 10 to EXOSENS SAS (EXENS.PA). This can be considered as Overvalued.
Can you provide the profitability details for EXOSENS SAS?
EXOSENS SAS (EXENS.PA) has a profitability rating of 4 / 10.
What are the PE and PB ratios of EXOSENS SAS (EXENS.PA) stock?
The Price/Earnings (PE) ratio for EXOSENS SAS (EXENS.PA) is 63.92 and the Price/Book (PB) ratio is 5.61.
What is the financial health of EXOSENS SAS (EXENS.PA) stock?
The financial health rating of EXOSENS SAS (EXENS.PA) is 7 / 10.